Cadence Pharmaceuticals, Inc.' CEO Ted Schroeder To Present At The JMP Securities 11th Annual Research Conference In San Francisco On May 15, 2012

SAN DIEGO, May 11, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's President and CEO Ted Schroeder will present the company's corporate overview on Tuesday, May 15, 2012 at 2:00pm Pacific Time (5:00pm Eastern Time) during the JMP Securities 11th Annual Research Conference at the Ritz-Carlton Hotel in San Francisco.

The presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at www.cadencepharm.com in the Investor Relations section. A replay of the webcast will be available approximately three hours following the live webcast and will be archived for 30 days.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting. The current version of Cadence Pharmaceuticals' corporate overview may be viewed on the "Investors" page of www.cadencepharm.com, under "Events and Presentations."

SOURCE Cadence Pharmaceuticals, Inc.